Frederike Cosima Oertel, MD, PhD

Title(s)Postdoctoral Scholar, Neurology
SchoolSchool of Medicine
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Charité-Universitätsmedizin Berlin, Berlin, GermanyMD07/2019Medicine
    Charité-Universitätsmedizin Berlin, Berlin, GermanyMD/PhD03/2021Clinical Neuroimmunology
    University of California, San Francisco, San Francisco, CAFellowshipNeuroimmunology
    Collapse Awards and Honors
    NMSS (National Multiple Sclerosis Society)2021  - 2024Postdoctoral Fellowship
    AAN (American Academy of Neurology)2021  - 2023Neuroscience Research Training Scholarship Award
    Alzheimer's Assocation2021Travel Grant
    ECTRIMS2016  - 2020Travel / Educational Grants (annual)
    Research Day Multiple Sclerosis 2019, Berlin2019Poster Prize
    German National Academic Foundation 2012  - 2019Scholarship
    German Association for Audiology (“DGA”) 2017Publication Award
    Berlin Institute of Health (BIH)2016M.D. Student Research Scholarship
    Berlin Institute of Health (BIH)2016Mobility and Innovation Fund

    Collapse Overview 
    Collapse Overview
    I am a postdoctoral scholar in the Department of Neurology, University of California San Francisco. I completed my M.D. from Charité-Universitätsmedizin Berlin, Germany, the largest university hospital in Europe, and my M.D./Ph.D., for which I was associated with the Clinical Neuroimmunology Department of the Cluster of Excellence NeuroCure at Charité-Universitätsmedizin Berlin.

    Coming from a research background focusing mostly on the development of new diagnostic instruments for multiple sclerosis (MS) and related disorders, I am now planning to strongly endorse my scientific understanding of both basic research and clinical trials in order to foster my future translational career. My major areas of interest are 1.) the understanding of afferent visual system involvement in MS and related disorders, 2.) the utilization of the afferent visual system as the ideal model to clarify structure-function associations and the functional relevance of different disease components and 3.) the development of neuroprotective and regenerative therapies for MS. Especially developing a regenerative therapy for MS patients to improve their functional abilities is my personal goal and it made me want to dedicate my career towards translational MS research. Long-term, I want to help contribute scientifically to a faster diagnostic process and an improved treatment in MS whilst simultaneously becoming the best possible MS specialist for my patients.

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Distinctive waves of innate immune response in the retina in experimental autoimmune encephalomyelitis. JCI Insight. 2021 Jun 08; 6(11). Cruz-Herranz A, Oertel FC, Kim K, Cantó E, Timmons G, Sin JH, Devereux M, Baker N, Michel B, Schubert RD, Rani L, Cordano C, Baranzini SE, Green AJ. PMID: 34100385.
      View in: PubMed   Mentions: 1     Fields:    
    2. Serum GFAP and NfL as disease severity and prognostic biomarkers in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder. J Neuroinflammation. 2021 May 01; 18(1):105. Schindler P, Grittner U, Oechtering J, Leppert D, Siebert N, Duchow AS, Oertel FC, Asseyer S, Kuchling J, Zimmermann HG, Brandt AU, Benkert P, Reindl M, Jarius S, Paul F, Bellmann-Strobl J, Kuhle J, Ruprecht K. PMID: 33933106.
      View in: PubMed   Mentions:    Fields:    
    3. [Differential diagnostics of autoimmune inflammatory spinal cord diseases]. Nervenarzt. 2021 Mar 25. Oertel FC, Scheel M, Chien C, Bischof A, Finke C, Paul F. PMID: 33765163.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Foveal changes in aquaporin-4 antibody seropositive neuromyelitis optica spectrum disorder are independent of optic neuritis and not overtly progressive. Eur J Neurol. 2021 Jul; 28(7):2280-2293. Roca-Fernández A, Oertel FC, Yeo T, Motamedi S, Probert F, Craner MJ, Sastre-Garriga J, Zimmermann HG, Asseyer S, Kuchling J, Bellmann-Strobl J, Ruprecht K, Leite MI, Paul F, Brandt AU, Palace J. PMID: 33547839.
      View in: PubMed   Mentions: 1     Fields:    
    5. Lateral geniculate nucleus volume changes after optic neuritis in neuromyelitis optica: A longitudinal study. Neuroimage Clin. 2021; 30:102608. Papadopoulou A, Oertel FC, Chien C, Kuchling J, Zimmermann HG, Siebert N, Motamedi S, Souza M, Asseyer S, Bellmann-Strobl J, Ruprecht K, Chakravarty MM, Scheel M, Magon S, Wuerfel J, Paul F, Brandt AU. PMID: 33735786.
      View in: PubMed   Mentions:    Fields:    
    6. Beneficial effects of autologous mesenchymal stem cell transplantation in active progressive multiple sclerosis. Brain. 2020 12 01; 143(12):3574-3588. Petrou P, Kassis I, Levin N, Paul F, Backner Y, Benoliel T, Oertel FC, Scheel M, Hallimi M, Yaghmour N, Hur TB, Ginzberg A, Levy Y, Abramsky O, Karussis D. PMID: 33253391.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    7. Longitudinal analysis of primary and secondary factors related to fatigue in multiple sclerosis. Acta Neurol Belg. 2021 Feb; 121(1):271-274. Schließeit J, Oertel FC, Cooper G, Brandt AU, Bellmann-Strobl J. PMID: 33185857.
      View in: PubMed   Mentions:    Fields:    
    8. Retinal INL Thickness in Multiple Sclerosis: A Mere Marker of Neurodegeneration? Ann Neurol. 2021 01; 89(1):192-193. Cordano C, Yiu HH, Oertel FC, University of California, San Francisco MS-EPIC Team , Gelfand JM, Hauser SL, Cree BAC, Green AJ. PMID: 33067847.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    9. Cohort profile: a collaborative multicentre study of retinal optical coherence tomography in 539 patients with neuromyelitis optica spectrum disorders (CROCTINO). BMJ Open. 2020 10 29; 10(10):e035397. Specovius S, Zimmermann HG, Oertel FC, Chien C, Bereuter C, Cook LJ, Lana Peixoto MA, Fontenelle MA, Kim HJ, Hyun JW, Jung SK, Palace J, Roca-Fernandez A, Diaz AR, Leite MI, Sharma SM, Ashtari F, Kafieh R, Dehghani A, Pourazizi M, Pandit L, Dcunha A, Aktas O, Ringelstein M, Albrecht P, May E, Tongco C, Leocani L, Pisa M, Radaelli M, Martinez-Lapiscina EH, Stiebel-Kalish H, Hellmann M, Lotan I, Siritho S, de Seze J, Senger T, Havla J, Marignier R, Tilikete C, Cobo Calvo A, Bichuetti DB, Tavares IM, Asgari N, Soelberg K, Altintas A, Yildirim R, Tanriverdi U, Jacob A, Huda S, Rimler Z, Reid A, Mao-Draayer Y, de Castillo IS, Yeaman MR, Smith TJ, Brandt AU, Paul F, GJCF International Clinical Consortium for NMOSD . PMID: 33122310.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. Ventral posterior nucleus volume is associated with neuropathic pain intensity in neuromyelitis optica spectrum disorders. Mult Scler Relat Disord. 2020 Nov; 46:102579. Asseyer S, Kuchling J, Gaetano L, Komnenic D, Siebert N, Chien C, Scheel M, Oertel FC, Ruprecht K, Bellmann-Strobl J, Finke C, Chakravarty MM, Magon S, Wuerfel J, Paul F, Papadopoulou A, Brandt AU. PMID: 33296976.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    11. Visual system damage and network maladaptation are associated with cognitive performance in neuromyelitis optica spectrum disorders. Mult Scler Relat Disord. 2020 Oct; 45:102406. Chavarro VS, Bellmann-Strobl J, Zimmermann HG, Scheel M, Chien C, Oertel FC, Weygandt M, Ruprecht K, Paul F, Finke C, Brandt AU. PMID: 32707533.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    12. Altered fovea in AQP4-IgG-seropositive neuromyelitis optica spectrum disorders. Neurol Neuroimmunol Neuroinflamm. 2020 09; 7(5). Motamedi S, Oertel FC, Yadav SK, Kadas EM, Weise M, Havla J, Ringelstein M, Aktas O, Albrecht P, Ruprecht K, Bellmann-Strobl J, Zimmermann HG, Paul F, Brandt AU. PMID: 32576604.
      View in: PubMed   Mentions: 10     Fields:    
    13. Functionally Relevant Maculopathy and Optic Atrophy in Spinocerebellar Ataxia Type 1. Mov Disord Clin Pract. 2020 Jul; 7(5):502-508. Oertel FC, Zeitz O, Rönnefarth M, Bereuter C, Motamedi S, Zimmermann HG, Kuchling J, Grosch AS, Doss S, Browne A, Paul F, Schmitz-Hübsch T, Brandt AU. PMID: 32626794.
      View in: PubMed   Mentions:
    14. Optic chiasm measurements may be useful markers of anterior optic pathway degeneration in neuromyelitis optica spectrum disorders. Eur Radiol. 2020 Sep; 30(9):5048-5058. Juenger V, Cooper G, Chien C, Chikermane M, Oertel FC, Zimmermann H, Ruprecht K, Jarius S, Siebert N, Kuchling J, Papadopoulou A, Asseyer S, Bellmann-Strobl J, Paul F, Brandt AU, Scheel M. PMID: 32335748.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    15. Understanding neurodegenerative changes of the afferent visual pathway in MS. Neurol Neuroimmunol Neuroinflamm. 2020 03 05; 7(2). Zimmermann HG, Oertel FC. PMID: 32229640.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    16. Imaging markers of disability in aquaporin-4 immunoglobulin G seropositive neuromyelitis optica: a graph theory study. Brain Commun. 2019; 1(1):fcz026. Chien C, Oertel FC, Siebert N, Zimmermann H, Asseyer S, Kuchling J, Scheel M, Ruprecht K, Bellmann-Strobl J, Paul F, Brandt AU. PMID: 32954267.
      View in: PubMed   Mentions:
    17. Optical coherence tomography in myelin-oligodendrocyte-glycoprotein antibody-seropositive patients: a longitudinal study. J Neuroinflammation. 2019 Jul 25; 16(1):154. Oertel FC, Outteryck O, Knier B, Zimmermann H, Borisow N, Bellmann-Strobl J, Blaschek A, Jarius S, Reindl M, Ruprecht K, Meinl E, Hohlfeld R, Paul F, Brandt AU, Kümpfel T, Havla J. PMID: 31345223.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    18. Frequency of autoimmune disorders and autoantibodies in European patients with neuromyelitis optica spectrum disorders. Acta Neurol Belg. 2020 Feb; 120(1):223-225. Gkaniatsou T, Papadopoulou A, Paul F, Brandt AU, Oertel FC. PMID: 31264181.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    19. Cognitive Impairment in Neuromyelitis Optica Spectrum Disorders: A Review of Clinical and Neuroradiological Features. Front Neurol. 2019; 10:608. Oertel FC, Schließeit J, Brandt AU, Paul F. PMID: 31258505.
      View in: PubMed   Mentions:
    20. Attack-related damage of thalamic nuclei in neuromyelitis optica spectrum disorders. J Neurol Neurosurg Psychiatry. 2019 10; 90(10):1156-1164. Papadopoulou A, Oertel FC, Gaetano L, Kuchling J, Zimmermann H, Chien C, Siebert N, Asseyer S, Bellmann-Strobl J, Ruprecht K, Chakravarty MM, Scheel M, Magon S, Wuerfel J, Paul F, Brandt AU. PMID: 31127016.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    21. Novel uses of retinal imaging with optical coherence tomography in multiple sclerosis. Expert Rev Neurother. 2019 01; 19(1):31-43. Oertel FC, Zimmermann HG, Brandt AU, Paul F. PMID: 30587061.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    22. [Optical Coherence Tomography in Disorders of the Central Nervous System]. Klin Monbl Augenheilkd. 2018 Nov; 235(11):1242-1258. Papadopoulou A, Oertel FC, Zimmermann H, Zeitz O, Brandt AU, Paul F. PMID: 30458564.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    23. Retinal ganglion cell loss in neuromyelitis optica: a longitudinal study. J Neurol Neurosurg Psychiatry. 2018 12; 89(12):1259-1265. Oertel FC, Havla J, Roca-Fernández A, Lizak N, Zimmermann H, Motamedi S, Borisow N, White OB, Bellmann-Strobl J, Albrecht P, Ruprecht K, Jarius S, Palace J, Leite MI, Kuempfel T, Paul F, Brandt AU. PMID: 29921610.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    24. Comparison of probabilistic tractography and tract-based spatial statistics for assessing optic radiation damage in patients with autoimmune inflammatory disorders of the central nervous system. Neuroimage Clin. 2018; 19:538-550. Kuchling J, Backner Y, Oertel FC, Raz N, Bellmann-Strobl J, Ruprecht K, Paul F, Levin N, Brandt AU, Scheel M. PMID: 29984162.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    25. Association of Visual Impairment in Neuromyelitis Optica Spectrum Disorder With Visual Network Reorganization. JAMA Neurol. 2018 03 01; 75(3):296-303. Finke C, Zimmermann H, Pache F, Oertel FC, Chavarro VS, Kramarenko Y, Bellmann-Strobl J, Ruprecht K, Brandt AU, Paul F. PMID: 29297041.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    26. Retinal optical coherence tomography shows optic disc changes in low intracranial pressure headaches: a case report. Acta Neurol Belg. 2018 Mar; 118(1):131-133. Oertel FC, Bosello F, Petzold A. PMID: 29299774.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    27. Optical coherence tomography in neuromyelitis optica spectrum disorders: potential advantages for individualized monitoring of progression and therapy. EPMA J. 2018 Mar; 9(1):21-33. Oertel FC, Zimmermann H, Paul F, Brandt AU. PMID: 29515685.
      View in: PubMed   Mentions:
    28. [Optical coherence tomography in neuromyelitis optica spectrum disorders]. Nervenarzt. 2017 Dec; 88(12):1411-1420. Oertel FC, Zimmermann H, Brandt AU, Paul F. PMID: 29119196.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    29. CuBe: parametric modeling of 3D foveal shape using cubic Bézier. Biomed Opt Express. 2017 Sep 01; 8(9):4181-4199. Yadav SK, Motamedi S, Oberwahrenbrock T, Oertel FC, Polthier K, Paul F, Kadas EM, Brandt AU. PMID: 28966857.
      View in: PubMed   Mentions:
    30. Contribution of blood vessels to retinal nerve fiber layer thickness in NMOSD. Neurol Neuroimmunol Neuroinflamm. 2017 May; 4(3):e338. Oertel FC, Zimmermann H, Mikolajczak J, Weinhold M, Kadas EM, Oberwahrenbrock T, Pache F, Bellmann-Strobl J, Ruprecht K, Paul F, Brandt AU. PMID: 28451626.
      View in: PubMed   Mentions: 9     Fields:    
    31. Microstructural visual system changes in AQP4-antibody-seropositive NMOSD. Neurol Neuroimmunol Neuroinflamm. 2017 May; 4(3):e334. Oertel FC, Kuchling J, Zimmermann H, Chien C, Schmidt F, Knier B, Bellmann-Strobl J, Korn T, Scheel M, Klistorner A, Ruprecht K, Paul F, Brandt AU. PMID: 28255575.
      View in: PubMed   Mentions: 41     Fields:    
    32. Severe structural and functional visual system damage leads to profound loss of vision-related quality of life in patients with neuromyelitis optica spectrum disorders. Mult Scler Relat Disord. 2017 Jan; 11:45-50. Schmidt F, Zimmermann H, Mikolajczak J, Oertel FC, Pache F, Weinhold M, Schinzel J, Bellmann-Strobl J, Ruprecht K, Paul F, Brandt AU. PMID: 28104256.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    33. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: Afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients. J Neuroinflammation. 2016 11 01; 13(1):282. Pache F, Zimmermann H, Mikolajczak J, Schumacher S, Lacheta A, Oertel FC, Bellmann-Strobl J, Jarius S, Wildemann B, Reindl M, Waldman A, Soelberg K, Asgari N, Ringelstein M, Aktas O, Gross N, Buttmann M, Ach T, Ruprecht K, Paul F, Brandt AU, in cooperation with the Neuromyelitis Optica Study Group (NEMOS) . PMID: 27802824.
      View in: PubMed   Mentions: 70     Fields:    Translation:Humans
    Frederike Cosima's Networks
    Concepts (85)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (6)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (59)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version v3.0.0-839-g49dc76ac on PROFILES-PWEB02.

    Copyright © The Regents of the University of California